HIV-1 immunogen (remune)
- PMID: 11367099
HIV-1 immunogen (remune)
Abstract
AIDS: The intended action of the HIV-1 Immunogen is to stimulate the immune systems of those already infected with HIV. The vaccine is made from an inactivated form of HIV that cannot replicate, but is believed to assist the immune system in building defenses against the virus. Skeptics are unsure of the effectiveness of the infertile vaccine. They wonder if an inactive form of the virus can stimulate an immune response when contact with the live virus does not elicit an adequate response. Complete results of the blinded study are still unknown; however, one group of participants is exhibiting improved HIV-specific CD4+ responses. If the vaccine, which has few side effects, proves effective, it would help to decrease dependence on antiviral treatments.
Similar articles
-
A boost for the immune system.TreatmentUpdate. 1998 Nov;10(9):3-4. TreatmentUpdate. 1998. PMID: 11365925 English, French.
-
A primer on HIV type 1-specific immune function and REMUNE.AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S167-75. AIDS Res Hum Retroviruses. 1998. PMID: 9672235 Review.
-
Immune based therapy update.Proj Inf Perspect. 1998 Sep;(25):17-9. Proj Inf Perspect. 1998. PMID: 11365845
-
The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.Expert Rev Vaccines. 2003 Dec;2(6):739-52. doi: 10.1586/14760584.2.6.739. Expert Rev Vaccines. 2003. PMID: 14711358 Review.
-
Therapeutic vaccine trails in Thailand.J HIV Ther. 2004 Sep;9(3):57-9. J HIV Ther. 2004. PMID: 15534562 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials